drugset / Trial / NCT01659281

Efficacy of Artesunate-Mefloquine Combination Therapy in Trat Province, Thailand

NCT01659281

RandomizedParallel-groupOpen-labelTreatment

Summary

The main purpose of this study is to compare artesunate-mefloquine combination therapy given for 2 and 3 days at the same total dose for the treatment of uncomplicated falciparum malaria.

Timeline

Start
2007-09
Primary completion
2008-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Artesunate Small molecule 4 mg/kg Oral
Comparator Artesunate Small molecule 6 mg/kg Oral
Comparator Mefloquine Unknown 8 mg/kg Oral
Comparator Mefloquine Unknown 10 mg/kg Oral
Comparator Mefloquine Unknown 15 mg/kg Oral